Viewing Study NCT00005934

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-09 @ 1:06 AM
Study NCT ID: NCT00005934
Status: COMPLETED
Last Update Posted: 2008-03-04
First Post: 2000-07-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Beta Thalassemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fetal Hemoglobin View
None 5-Azacytidine View
None Phenylbutyrate View
None Thalassemia View
None Hemoglobin View
None Anemia View
None Blood View
None Thalassemia Major View
None Beta Thalassemia View